INS and metabolic disease: Additionally, monoterpenes have been reported to stimulate insulin release from pancreatic β-cells, reduce cellular oxidative stress, and modulate enzymes, proteins, and pathways that contribute to the development of IR and other pathological events, and thus, they were emerged as promising natural molecules to treat DM and a vast range of metabolic disorders [65].